Stockwatch: Choppy Waters For Teva And Bausch

Could Black Swan Add To Generics Sector Woes?

 
• By Andy Smith
  
StockWatch_Andy-Smith_V1_1200.jpg
Andy Smith gives a life sciences investor's perspective on biopharma business

More from Earnings

More from Business